The large‐scale gene expression profiling in the present study showed that THAP10 acts as a transcriptional repressor to selectively modulate the enzyme‐linked receptor tyrosine kinase signalling cascade and cell differentiation in t(8;21) AML. Here, THAP10 is linked to acute myeloid leukemia.